Characteristics of patients stratified by HIV RNA levels below the limit of quantification and low-level viraemia defined as quantifiable HIV RNA levels <200 copies/mL and virological failure defined as HIV RNA levels ≥200 copies/mL.

<p>Abbreviations: LLV, low-level viraemia; VF, virological failure; VL, viral load; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI/r, boosted protease inhibitor; INSTI, integrase inhibitor; BLQ, below the limit of quantification; cART, combination antiretroviral therapy;</p><p>¹ Comparison between quantifiable HIV RNA levels <200 copies/mL (LLV) and HIV RNA levels below the limit of quantification (BLQ).</p><p>² Comparison between HIV RNA levels ≥200 copies/mL (VF) and HIV RNA levels below the limit of quantification (BLQ).</p><p>³ Interruptions prior to 6 months stable cART of the respective cART regimen.</p><p>⁴ Diabetes mellitus prior to 6 months stable cART of the respective cART regimen.</p><p>⁵ cART duration until 6 months stable cART of the respective cART regimen.</p><p>⁶ Whether the respective cART regimen is a first-line cART or not.</p><p>Characteristics of patients stratified by HIV RNA levels below the limit of quantification and low-level viraemia defined as quantifiable HIV RNA levels <200 copies/mL and virological failure defined as HIV RNA levels ≥200 copies/mL.</p

Univariable and multivariable logistic regression results: Association between different factors and low-level viraemia as well as virological failure compared to HIV RNA levels below the limit of quantification.

<p>Abbreviations: LLV, low-level viraemia; VF, virological failure; VL, viral load; CI, confidence interval; OR, odds ratio; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI/r, boosted protease inhibitor; INSTI, integrase inhibitor; cART, combination antiretroviral therapy;</p><p>¹ Interruptions prior to 6 months stable cART of the respective cART regimen.</p><p>² Diabetes mellitus prior to 6 months stable cART of the respective cART regimen.</p><p>³ cART duration until 6 months stable cART of the respective cART regimen.</p><p>⁴ Whether the respective cART regimen is a first-line cART or not.</p><p>Univariable and multivariable logistic regression results: Association between different factors and low-level viraemia as well as virological failure compared to HIV RNA levels below the limit of quantification.</p